Skip to main content
Loading…

Chamber and committees

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

  • Written questions must be answered within 10 working days (20 working days during recess)
  • Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search.  There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Filter your results Hide all filters

Dates of parliamentary sessions
  1. Session 1: 12 May 1999 to 31 March 2003
  2. Session 2: 7 May 2003 to 2 April 2007
  3. Session 3: 9 May 2007 to 22 March 2011
  4. Session 4: 11 May 2011 to 23 March 2016
  5. Session 5: 12 May 2016 to 4 May 2021
  6. Session 6: 13 May 2021 to 8 April 2026
  7. Current session: 14 May 2026 to 22 November 2026
Answer status
Question type

Displaying 1153 questions Show Answers

Order by |

Question reference: S3W-38117

  • Asked by: Elaine Smith, MSP for Coatbridge and Chryston, Scottish Labour
  • Date lodged: Tuesday, 07 December 2010
  • Current Status: Answered by Shona Robison on 16 December 2010

To ask the Scottish Executive what evidence it has of any complications arising from the use of generic rather than branded forms of thyroxine.

Question reference: S3W-38118

  • Asked by: Elaine Smith, MSP for Coatbridge and Chryston, Scottish Labour
  • Date lodged: Tuesday, 07 December 2010
  • Current Status: Answered by Shona Robison on 16 December 2010

To ask the Scottish Executive what guidelines it provides to pharmacies regarding prescriptions for generic drugs for thyroid patients.

Question reference: S3W-38120

  • Asked by: Elaine Smith, MSP for Coatbridge and Chryston, Scottish Labour
  • Date lodged: Tuesday, 07 December 2010
  • Current Status: Answered by Shona Robison on 16 December 2010

To ask the Scottish Executive what action it is taking to ensure stability in the strength of drugs for thyroid patients.

Question reference: S3W-38122

  • Asked by: Elaine Smith, MSP for Coatbridge and Chryston, Scottish Labour
  • Date lodged: Tuesday, 07 December 2010
  • Current Status: Answered by Nicola Sturgeon on 16 December 2010

To ask the Scottish Executive when it last met representatives of the British Thyroid Association.

Question reference: S3W-38121

  • Asked by: Elaine Smith, MSP for Coatbridge and Chryston, Scottish Labour
  • Date lodged: Tuesday, 07 December 2010
  • Current Status: Answered by Shona Robison on 16 December 2010

To ask the Scottish Executive whether patients on branded forms of thyroxine have a more positive outcome than those on generic forms.

Question reference: S3W-38119

  • Asked by: Elaine Smith, MSP for Coatbridge and Chryston, Scottish Labour
  • Date lodged: Tuesday, 07 December 2010
  • Current Status: Answered by Shona Robison on 16 December 2010

To ask the Scottish Executive what advice it gives pharmacies and GPs to ensure that the same strength of drugs is provided to thyroid patients.

Question reference: S3W-38127

  • Asked by: Elaine Smith, MSP for Coatbridge and Chryston, Scottish Labour
  • Date lodged: Tuesday, 07 December 2010
  • Current Status: Answered by Nicola Sturgeon on 16 December 2010

To ask the Scottish Executive what guidelines it provides to GPs in relation to considering a potential thyroid patient’s blood test results.

Question reference: S3W-38126

  • Asked by: Elaine Smith, MSP for Coatbridge and Chryston, Scottish Labour
  • Date lodged: Tuesday, 07 December 2010
  • Current Status: Answered by Shona Robison on 16 December 2010

To ask the Scottish Executive what evidence it has of the benefits of the combined use of triiodothyronine and thyroxine compared with patients receiving only thyroxine.

Question reference: S3W-38124

  • Asked by: Elaine Smith, MSP for Coatbridge and Chryston, Scottish Labour
  • Date lodged: Tuesday, 07 December 2010
  • Current Status: Answered by Shona Robison on 16 December 2010

To ask the Scottish Executive whether it has guidelines on the combined use of triiodothyronine and levothyroxine in patients with hypothyroidism.

Question reference: S3W-38125

  • Asked by: Elaine Smith, MSP for Coatbridge and Chryston, Scottish Labour
  • Date lodged: Tuesday, 07 December 2010
  • Current Status: Answered by Shona Robison on 16 December 2010

To ask the Scottish Executive what percentage of people diagnosed with thyroid conditions is prescribed a combined course of triiodothyronine and thyroxine and what information it has on how this compares with the situation worldwide.